Not Yet Recruiting OBSERVATIONAL NCT06475651
Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset (FOETEPISIGN)
Sponsor: Assistance Publique - Hôpitaux de Paris
Interventions
Methylation analysis
Updated 2 times since 2024 Last updated: Jun 20, 2024 Started: Jun 30, 2024 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Congenital Malformation and Rare Fetal Genetic Diseases, this trial is actively recruiting participants. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
First recorded
Jun 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Assistance Publique - Hôpitaux de Paris
Data source: Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .